Have a personal or library account? Click to login

References

  1. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990‑2021: A systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):11991226. doi:10.1016/S0140-6736(24)01867-1.
  2. World Health Organization. Antimicrobial Resistance [Internet]. 2023. Accessed August 12, 2024. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
  3. World Health Organization. WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. Geneva: World Health Organization; 2024. Licence: CC BY‑NC‑SA 3.0 IGO.
  4. European Centre for Disease Prevention and Control. Surveillance of Antimicrobial Resistance in Europe 2021 [Internet]. 2022. Accessed August 12, 2024. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2021.
  5. Wang X, Liu J, Li A. Incidence and risk factors for subsequent infections among rectal carriers with carbapenem‑resistant Klebsiella pneumoniae: A systematic review and meta‑analysis. J Hosp Infect. 2024;145:1121. doi:10.1016/j.jhin.2023.12.002.
  6. Graham DW, Bergeron G, Bourassa MW, et al. Complexities in understanding antimicrobial resistance across domesticated animal, human, and environmental systems. Ann N Y Acad Sci. 2019;1441(1):1730. doi:10.1111/nyas.14036.
  7. World Health Organization, Food and Agriculture Organization of the United Nations, United Nations Environment Programme, World Organization for Animal Health. A One Health Priority Research Agenda for Antimicrobial Resistance. Geneva: World Health Organization; 2023. ISBN: 978‑92‑4‑007592‑4.
  8. Bertagnolio S, Dobreva Z, Centner CM, et al. WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe. 2024;5(11):100902.
  9. Martinez L, Garcia‑Basteiro AL. Targeting vulnerable populations for tuberculosis: Does one size fit all? Lancet Infect Dis. 2023;23(12):13321333. doi:10.1016/S1473-3099(23)00429-2.
  10. International Organization for Migration. World Migration Report 2024. Geneva: International Organization for Migration; 2024. https://worldmigrationreport.iom.int.
  11. Iskandar K, Molinier L, Hallit S, et al. Surveillance of antimicrobial resistance in low‑ and middle‑income countries: A scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63. doi:10.1186/s13756-021-00931-w.
  12. Rousham EK, Unicomb L, Islam MA. Human, animal and environmental contributors to antibiotic resistance in low‑resource settings: Integrating behavioural, epidemiological and One Health approaches. Proc Biol Sci. 2018;285(1876):20180332.
  13. United Nations High Commissioner for Refugees (UNHCR). Global Trends Report 2023 [Internet]. UNHCR; 2023. Accessed October 10, 2024. https://www.unhcr.org/global-trends-report-2023.
  14. Internal Displacement Monitoring Centre. Global Report on Internal Displacement 2024 [Internet]. Geneva: IDMC; 2024. Accessed October 10, 2024. https://www.internal-displacement.org/global-report/grid2024/.
  15. Kamiab Hesari D, Aljadeeah S, Brhlikova P, et al. Access to and utilisation of antimicrobials among forcibly displaced persons in Uganda, Yemen and Colombia: A pilot cross‑sectional survey. BMJ Open. 2024;14(7):e084734. doi:10.1136/bmjopen-2024-084734.
  16. Nellums LB, Thompson H, Holmes A, et al. Antimicrobial resistance among migrants in Europe: A systematic review and meta‑analysis. Lancet Infect Dis. 2018;18(7):796811. doi:10.1016/S1473-3099(18)30219-6.
  17. WHO. Worldwide Country Situation Analysis: Response to Antimicrobial Resistance. 2015. http://apps.who.int/iris/bitstream/10665/163468/1/9789241564946_eng.pdf?ua=1.
  18. Chukwudile B, Pan D, Silva L, et al. Antimicrobial resistance among migrants in Europe: A systematic review and meta‑analysis – update from 2017 to 2023. eClinicalMedicine. 2024;75:102801. doi:10.1016/j.eclinm.2024.102801.
  19. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399(10325):629655. doi:10.1016/S0140-6736(21)02724-0.
  20. Nielsen RT, Köse G, Sloth L, Andersen , Petersen JH, Norredam M. Pathogen distribution and antimicrobial resistance in infections in migrants and nonmigrants in Denmark, a cross‑sectional study. Trop Med Int Health. 2022;27(11):9991008. doi:10.1111/tmi.13820.
  21. Heudorf U, Albert‑Braun S, Hunfeld KP, et al. Multidrug‑resistant organisms in refugees: prevalences and impact on infection control in hospitals. GMS Hyg Infect Control. 2016;11:Doc16. Published 2016 Aug 9. doi:10.3205/dgkh000276.
  22. Ravensbergen SJ, Berends M, Stienstra Y, Ott A. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One. 2017;12(4):e0176481. doi:10.1371/journal.pone.0176481.
  23. Reinheimer C, Abdollahi P, Zacharowski K, et al. Prevalence of multidrug‑resistant organisms in refugee patients admitted to a German university hospital depending on duration of stay in Germany. GMS Hyg Infect Control. 2019;14:Doc07. doi:10.3205/dgkh000323.
  24. Creutz I, Busche T, Layer F, Bednarz H, Kalinowski J, Niehaus K. Evaluation of virulence potential of methicillin‑sensitive and methicillin‑resistant Staphylococcus aureus isolates from a German refugee cohort. Travel Med Infect Dis. 2021:102204. doi:10.1016/j.tmaid.2021.102204.
  25. Møller JK, Larsen AR, Østergaard C, Møller CH, Kristensen MA, Larsen J. International travel as source of a hospital outbreak with an unusual meticillin‑resistant Staphylococcus aureus clonal complex 398, Denmark, 2016. Euro Surveill. 2019;24(42):1800680. doi:10.2807/1560-7917.ES.2019.24.42.1800680.
  26. Aro T, Kantele A. High rates of meticillin‑resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017. Euro Surveill. 2018;23(45):1700797. doi:10.2807/1560-7917.ES.2018.23.45.1700797.
  27. Piso RJ, Käch R, Pop R, et al. A Cross‑Sectional Study of Colonization Rates with Methicillin‑Resistant Staphylococcus aureus (MRSA) and Extended‑Spectrum Beta‑Lactamase (ESBL) and Carbapenemase‑Producing Enterobacteriaceae in Four Swiss Refugee Centres [published correction appears in PLoS One. 2017 Mar 27;12(3):e0174911. doi:10.1371/journal.pone.0174911]. PLoS One. 2017;12(1):e0170251. Published January 13, 2017. doi:10.1371/journal.pone.0170251.
  28. Ciccozzi M, Cella E, Ceccarelli G, et al. Sentinel surveillance data from Eritrean migrants in Italy: The theory of “Healthy Migrants.” Travel Med Infect Dis. 2018;22:5865. doi:10.1016/j.tmaid.2017.09.004.
  29. Yıldız SS, Hekimoğlu CH, Sucaklı MB, et al. Community‑acquired antimicrobial resistance among Syrian refugees and the local population in Türkiye. Eur J Public Health. 2023;33(5):809814. doi:10.1093/eurpub/ckad119.
  30. Osman M, Rafei R, Ismail MB, et al. Antimicrobial resistance in the protracted Syrian conflict: Halting a war in the war. Future Microbiol. 2021;16:825845. doi:10.2217/fmb-2021-0040.
  31. Sloth LB, Nielsen RT, Østergaard C, et al. Antibiotic resistance patterns of Escherichia coli in migrants vs non‑migrants: A study of 14,561 urine samples. J Travel Med. 2019;26(8):taz080. doi:10.1093/jtm/taz080.
  32. Heudorf U, Albert‑Braun S, Hunfeld KP, et al. Multidrug‑resistant organisms in refugees: Prevalences and impact on infection control in hospitals. GMS Hyg Infect Control. 2016;11:19.
  33. Reinheimer C, Kempf VA, Jozsa K, et al. Prevalence of multidrug‑resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital. BMC Infect Dis. 2017;17(1):17. Published January 5, 2017. doi:10.1186/s12879-016-2105-y.
  34. Steger S, Demetz F, Schmidt C, Borgmann S. Low percentage of asylum seekers colonized with multi‑resistant bacteria treated at a German hospital. Jacobs J Epidemiol Prev Med. 2016;2(1):021.
  35. Ravensbergen SJ, Lokate M, Cornish D, et al. High prevalence of infectious diseases and drug‑resistant microorganisms in asylum seekers admitted to hospital; no carbapenemase‑producing Enterobacteriaceae until September 2015. PLoS One. 2016;11(5):e0154791. doi:10.1371/journal.pone.0154791.
  36. Peretz A, Labay K, Zonis Z, Glikman D. Disengagement does not apply to bacteria: A high carriage rate of antibiotic‑resistant pathogens among Syrian civilians treated in Israeli hospitals. Clin Infect Dis. 2014;59(5):753754. doi:10.1093/cid/ciu374.
  37. Heudorf U, Krackhardt B, Karathana M, et al. Multidrug‑resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015. Euro Surveill. 2016;21(2). doi:10.2807/1560–;7917.ES.2016.21.2.30109.
  38. Angeletti S, Ceccarelli G, Vita S, et al. Unusual microorganisms and antimicrobial resistances in a group of Syrian migrants: Sentinel surveillance data from an asylum seekers centre in Italy. Travel Med Infect Dis. 2016;14(2):115122. doi:10.1016/j.tmaid.2016.03.005.
  39. Hernando Rovirola C, Spiteri G, Sabidó M, et al. Antimicrobial resistance in neisseria gonorrhoeae isolates from foreign‑born population in the european gonococcal antimicrobial surveillance programme. Sex Transm Infect. 2020;96(3):204210. doi:10.1136/sextrans-2018-053912. PMID: 32019895; PMCID: PMC7231443.
  40. Centers for Disease Control and Prevention (CDC). Laboratory recommendations for syphilis testing, United States, 2024. Accessed September 21, 2024. https://www.cdc.gov/std/syphilis/Syphilis-Lab-Recommendations-2024.html.
  41. European Centre for Disease Prevention and Control (ECDC). Syphilis: Annual epidemiological report for 2022. Accessed September 21, 2024. https://www.ecdc.europa.eu/en/publications-data/syphilis-annual-epidemiological-report-2022.
  42. Orbe‑Orihuela YC, Sánchez‑Alemán , Hernández‑Pliego A, Medina‑García CV, Vergara‑Ortega DN. Syphilis as re‑emerging disease, antibiotic resistance, and vulnerable population: Global systematic review and meta‑analysis. Pathogens. 2022;11(12):1546. doi:10.3390/pathogens11121546.
  43. World Health Organization (WHO). Drug‑resistant TB: Global tuberculosis report 2022. Accessed September 21, 2024. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/tb-disease-burden/2-3-drug-resistant-tb.
  44. Nellums LB, Rustage K, Hargreaves S, Friedland JS. Multidrug‑resistant tuberculosis treatment adherence in migrants: A systematic review and meta‑analysis. BMC Med. 2018;16:27. doi:10.1186/s12916-017-1001-7.
  45. European Commission. Statistics on migration in Europe. Accessed September 21, 2024. https://commission.europa.eu/strategy-and-policy/priorities-2019-2024/promoting-our-european-way-life/statistics-migration-europe_en#refugees-in-europe.
  46. United Nations Department of Economic and Social Affairs. International migrant stock. Accessed September 21, 2024. https://www.un.org/development/desa/pd/content/international-migrant-stock.
  47. Tsourdi EL, De Bruycker P, eds. Research Handbook on EU Migration and Asylum Law. Edward Elgar Publishing; 2021.
  48. Hannigan A, O’Donnell P, O’Keeffe M, MacFarlane A. How do Variations in Definitions of “Migrant” and their Application Influence the Access of Migrants to Health Care Services? [Internet]. Copenhagen: WHO Regional Office for Europe; 2016. PMID: 27809422.
  49. Chen Q, Li D, Beiersmann C, et al. Risk factors for antibiotic resistance development in healthcare settings in China: A systematic review. Epidemiol Infect. 2021;149:e141. Published June 3, 2021. doi:10.1017/S0950268821001254.
  50. Saad NJ, Bowles CC, Grenfell BT, et al. The impact of migration and antimicrobial resistance on the transmission dynamics of typhoid fever in Kathmandu, Nepal: A mathematical modelling study. PLoS Negl Trop Dis. 2017;11(5):e0005547. Published May 5, 2017. doi:10.1371/journal.pntd.0005547.
  51. Kadariya J, Thapaliya D, Bhatta S, et al. Multidrug‑resistant Staphylococcus aureus colonization in healthy adults is more common in Bhutanese refugees in Nepal than those resettled in Ohio. Biomed Res Int. 2019;2019:5739247. doi:10.1155/2019/5739247.
  52. Hermsen ED, Amos J, Townsend A, et al. Antimicrobial resistance among refugees and asylum seekers: A global systematic review and meta‑analysis. Lancet Infect Dis. Published online November 8, 2024. doi:10.1016/S1473-3099(24)00578-4.
  53. Alividza V, Mariano V, Ahmad R, et al. Investigating the impact of poverty on colonization and infection with drug‑resistant organisms in humans: A systematic review. Infect Dis Poverty. 2018;7(1):76. doi:10.1186/s40249-018-0459-7. PMID: 30115132; PMCID: PMC6097281.
  54. Nilsson P, Laurell MH. Impact of socioeconomic factors and antibiotic prescribing on penicillin‑non‑susceptible Streptococcus pneumoniae in the city of Malmö. Scand J Infect Dis. 2005;37(6–7):43641. doi:10.1080/00365540510037795. PMID: 16012003.
  55. World Health Organization (WHO). Refugee and migrant health. WHO website. Accessed July 22, 2024. https://www.who.int/news-room/fact-sheets/detail/refugee-and-migrant-health.
  56. European Council on Refugees and Exiles. Conditions in reception facilities. AIDA ‑ Asylum Information Database. Accessed July 22, 2024. https://asylumineurope.org/reports/country/italy/reception-conditions/housing/conditions-reception-facilities/.
  57. Kleinert E, Hillermann N, Jablonka A, Happle C, Müller F, Simmenroth A. Prescription of antibiotics in the medical care of newly arrived refugees and migrants. Pharmacoepidemiol Drug Saf. 2021;30(8):10741083. doi:10.1002/pds.5254. PMID: 33886141.
  58. Nanakali SS, Hassan O, Silva L, et al. Migrants’ living conditions, perceived health needs and implications for the use of antibiotics and antimicrobial resistance in the United Kingdom: A qualitative study. Health Sci Rep. 2023;6(10):e1655. doi:10.1002/hsr2.1655.
  59. Lindenmeyer A, Redwood S, Griffith L, Ahmed S, Phillimore J. Recent migrants’ perspectives on antibiotic use and prescribing in primary care: A qualitative study. Br J Gen Pract. 2016;66(652):e802e809. doi:10.3399/bjgp16X686809.
  60. Lescure DLA, van Oorschot W, Brouwer R, et al. Providing antibiotics to immigrants: A qualitative study of general practitioners’ and pharmacists’ experiences. BMC Prim Care. 2022;23(1):100. doi:10.1186/s12875-022-01706-x. PMID: 35501699; PMCID: PMC9058745.
  61. Ladines‑Lim J, Scruggs‑Wodkowski E, Adžemović T, et al. Understanding refugee and immigrant health literacy and beliefs toward antimicrobial resistance. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e175. doi:10.1017/ash.2023.443. PMID: 38028894; PMCID: PMC10644158.
  62. Browne AJ, Chipeta MG, Haines‑Woodhouse G, et al. Global antibiotic consumption and usage in humans, 2000–18: A spatial modelling study. Lancet Planet Health. 2021;5(12):e893e904. doi:10.1016/S2542-5196(21)00280-1. PMID: 34774223; PMCID: PMC8654683.
  63. Arcilla JT, Nanou A, Hamed S, Osman F. Racialized migrant women’s discrimination in maternal care: A scoping review. Int J Equity Health. 2025;24(1):16. Published Jan 20, 2025. doi:10.1186/s12939-025-02384-8.
  64. McBride B, Shannon K, Strathdee SA, Goldenberg SM. Structural determinants of HIV/STI prevalence, HIV/STI/sexual and reproductive health access, and condom use among immigrant sex workers globally. AIDS. 2021;35(9):14611477. doi:10.1097/QAD.0000000000002910.
  65. Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: The role of international travel. J Travel Med. 2019;26(8):taz036. doi:10.1093/jtm/taz036.
  66. Herdman MT, Karo B, Dave J, et al. Increasingly limited options for the treatment of enteric fever in travellers returning to England, 2014–2019: A cross‑sectional analytical study. J Med Microbiol. 2021;70(8):001359. doi:10.1099/jmm.0.001359.
  67. Monsálvez V, Bierge P, Machado ML, et al. Prevalence and risk factors for colonization by multidrug‑resistant microorganisms among long‑term travelers and recently arrived migrants. Microorganisms. 2024;12(5):936. Published May 4, 2024. doi:10.3390/microorganisms12050936.
  68. Thomas CM, Morkeberg OH, Walker PF, Stauffer WM. The cost of global connectivity: Faster and more efficient spread of antimicrobial resistance by international travelers – A controversial commentary. Travel Med Infect Dis. May‑June 2021;41:102045. doi:10.1016/j.tmaid.2021.102045. Epub 2021 Mar 30. PMID: 33798743.
  69. Ravensbergen SJ, Louka C, Ott A, et al. Proportion of asylum seekers carrying multi‑drug resistant microorganisms is persistently increased after arrival in the Netherlands. Antimicrob Resist Infect Control. January 7, 2019;8:6. doi:10.1186/s13756-018-0455-5. PMID: 30637100; PMCID: PMC6323800.
  70. Abbara A, Rawson TM, Karah N, et al. Antimicrobial resistance in the context of the Syrian conflict: Drivers before and after the onset of conflict and key recommendations. Int J Infect Dis. 2018;73:16. doi:10.1016/j.ijid.2018.05.008.
  71. Bazzi W, Abou Fayad AG, Nasser A, et al. Heavy metal toxicity in armed conflicts potentiates AMR in A. baumannii by selecting for antibiotic and heavy metal co‑resistance mechanisms. Front Microbiol. 2020;11:68. Published February 3, 2020. doi:10.3389/fmicb.2020.00068.
  72. Petrosillo N, Petersen E, Antoniak S. Ukraine war and antimicrobial resistance. Lancet Infect Dis. June 2023;23(6):653654. doi:10.1016/S1473-3099(23)00264-5. Epub 2023 Apr 18. PMID: 37084755.
  73. Cojocaru E, Cojocaru C, Cojocaru E, Oancea CI. Health risks during the Ukrainian humanitarian crisis. Risk Manag Healthc Policy. September 22, 2022;15:17751781. doi:10.2147/RMHP.S375021. PMID: 36171868; PMCID: PMC9512537.
  74. Magnano San Lio R, Favara G, Maugeri A, Barchitta M, Agodi A. How antimicrobial resistance is linked to climate change: An overview of two intertwined global challenges. Int J Environ Res Public Health. January 17, 2023;20(3):1681. doi:10.3390/ijerph20031681. PMID: 36767043; PMCID: PMC9914631.
  75. Mulchandani R, Wang Y, Gilbert M, Van Boeckel TP. Global trends in antimicrobial use in food‑producing animals: 2020 to 2030. PLOS Glob Public Health. 2023;3(2):e0001305. doi:10.1371/journal.pgph.0001305.
  76. Conceição S, Queiroga MC, Laranjo M. Antimicrobial resistance in bacteria from meat and meat products: A One Health perspective. Microorganisms. October 17, 2023;11(10):2581. doi:10.3390/microorganisms11102581. PMID: 37894239; PMCID: PMC10609446.
  77. Dignard C, Leibler JH. Recent research on occupational animal exposures and health risks: A narrative review. Curr Envir Health Rpt. 2019;6:236246. doi:10.1007/s40572-019-00253-5.
  78. European Economic and Social Committee. Collecting Data on the Situation of Social Protection of Seasonal Workers in the Agriculture and Food Sectors in EU Member States After COVID‑19 [Internet]. Brussels: European Economic and Social Committee; 2023. https://www.eesc.europa.eu.
  79. Harvey EJ, De Brún C, Casale E, Finistrella V, Ashiru‑Oredope D. Influence of factors commonly known to be associated with health inequalities on antibiotic use in high‑income countries: A systematic scoping review. J Antimicrob Chemother. April 3, 2023;78(4):861870. doi:10.1093/jac/dkad034. PMID: 36814075.
  80. Schuts EC, van Dulm E, Boyd A, et al. Knowledge and use of antibiotics in six ethnic groups: The HELIUS study. Antimicrob Resist Infect Control. December 6, 2019;8:200. doi:10.1186/s13756-019-0636-x. PMID: 31827781; PMCID: PMC6898914.
  81. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non‑prescription antimicrobial use worldwide: A systematic review. Lancet Infect Dis. September 2011;11(9):692701. doi:10.1016/S1473-3099(11)70054-8. Epub 2011 Jun 12. PMID: 21659004; PMCID: PMC3543997.
  82. Mellou K, Mandilara G, Chrysostomou A, et al. Public health and clinical implications of multidrug‑resistant shigellosis cases in a reception centre for refugees/migrants, Greece, October‑December 2019. Eur J Public Health. July 13, 2021;31(3):588590. doi:10.1093/eurpub/ckaa220. PMID: 33313745.
  83. van Rosse F, de Bruijne M, Suurmond J, Essink‑Bot ML, Wagner C. Language barriers and patient safety risks in hospital care. A mixed methods study. Int J Nurs Stud. February 2016;54:4553. doi:10.1016/j.ijnurstu.2015.03.012. Epub 2015 Mar 25. PMID: 25840899.
  84. Bianchi FP, Fiacchini D, Frisicale EM, et al. Infectious risk profile and strategies for prevention and control of outbreaks in refugee, asylum seekers and migrant populations in EU/EEA countries: A systematic narrative review of evidence. Ann Ig. September‑October 2024;36(5):549568. doi:10.7416/ai.2024.2610. Epub 2024 Mar 28. PMID: 38436078.
  85. OECD/European Commission. Living conditions of immigrants. In: Indicators of Immigrant Integration 2023: Settling In. OECD Publishing; 2023. doi:10.1787/d303c268-en.
  86. European Website on Integration (EWSI). Migrants’ access to medium‑ and long‑term housing in the EU: Barriers, governance and good practices. Published June 22, 2023. Accessed September 15, 2024. https://ec.europa.eu/migrant-integration/news/migrants-access-to-medium-and-long-term-housing-in-the-eu-barriers-governance-and-good-practices.
  87. Urban Innovative Actions. UIA Cities: Innovative solutions for sustainable urban development. Accessed September 15, 2024. https://www.uia-initiative.eu/en/uia-cities.
  88. European Commission. Communication from the commission to the european parliament, the council, the european economic and social committee and the committee of the regions: Action plan on integration and inclusion 2021–2027. Published November 24, 2020. Accessed September 15, 2024. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52020DC0758.
  89. Kuehne A, van Boetzelaer E, Alfani P, et al. Health of migrants, refugees and asylum seekers in detention in Tripoli, Libya, 2018–2019: Retrospective analysis of routine medical programme data. PLoS One. 2021;16(6):e0252460. doi:10.1371/journal.pone.0252460.
  90. Totaro V, Patti G, Segala FV, et al. HIV‑HCV incidence in low‑wage agricultural migrant workers living in ghettos in Apulia region, Italy: A multicenter cross‑sectional study. Viruses. 2023;15(1):249. doi:10.3390/v15010249.
  91. World Health Organization. Capturing the Evidence on Access to Essential Antibiotics in Refugee and Migrant Populations. Geneva: WHO; 2022. (Global Evidence Review on Health and Migration (GEHM) series). Licence: CC BY‑NC‑SA 3.0 IGO.
  92. Gosselin A, Coulibaly K, Ravalihasy A, et al. Finding the missing link: When community‑based outreach in public space is key to engage migrants in health prevention programmes in Paris, France. J Epidemiol Community Health. 2020;74(8):668675. doi:10.1136/jech-2019-213394.
  93. Urrego‑Parra HN, Rodriguez‑Guerrero LA, Pastells‑Peiró R, et al. The health of migrant agricultural workers in Europe: A scoping review. J Immigr Minor Health. 2022;24(6):15801589. doi:10.1007/s10903-022-01330-y.
  94. Rural Health Information Hub. Migrant and seasonal farmworker health. Accessed September 16, 2024. https://www.ruralhealthinfo.org/topics/migrant-health#health-concerns.
  95. European Parliamentary Research Service. Economic impacts of artificial intelligence (AI). European Parliament Think Tank. Published February 2021. Accessed September 16, 2024. https://www.europarl.europa.eu/thinktank/en/document/EPRS_BRI(2021)689347.
  96. Imanpour S, McMaughan DJ. ‘You never know when you will need an antibiotic’: A qualitative study of structural barriers and cultural assumptions in antibiotic misuse among immigrants in the United States. J Health Serv Res Policy. 2024;29(4):266274. doi:10.1177/13558196241252748.
  97. Stockwell MS, Catallozzi M, Meyer D, et al. Improving care of upper respiratory infections among Latino Early Head Start parents. J Immigr Minor Health. 2010;12(6):925931. doi:10.1007/s10903-010-9326-8.
  98. Venables E, Whitehouse K, Spissu C, et al. The role of cultural mediators in addressing the mental health needs of migrants and refugees. Forced Migr Rev. 2021;66:3941. https://www.fmreview.org/issue66/venables-whitehouse-spissu-pizzi-alrousan-dicarlo.
  99. World Health Organization Regional Office for Europe. Use of Behavioural and Cultural Insights in 2021–2022 in the WHO European Region: Status Report. Copenhagen: WHO; 2023. Licence: CC BY‑NC‑SA 3.0 IGO.
  100. World Health Organization Regional Office for Europe. European Regional Action Framework for Behavioural and Cultural Insights for Equitable Health, 2022–2027. Resolution adopted at the 72nd Regional Committee for Europe; September 12–14, 2022; Tel Aviv, Israel. https://iris.who.int/handle/10665/362958.
  101. Price L, Gozdzielewska L, Young M, et al. Effectiveness of interventions to improve the public’s antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: A systematic review. J Antimicrob Chemother. 2018;73(6):14641478. doi:10.1093/jac/dky076.
  102. Comelli A, Gaviraghi A, Cattaneo P, et al. Antimicrobial resistance in migratory paths, refugees, asylum seekers, and internally displaced persons: A narrative review. Curr Trop Med Rep. 2024;11:153166. doi:10.1007/s40475-024-00322-2.
  103. Yusuff SI, Tajudeen YA, Oladunjoye IO, et al. The need to increase antimicrobial resistance surveillance among forcibly displaced persons (FDPs). Trop Dis Travel Med Vaccines. 2023;9:12. doi:10.1186/s40794-023-00198-6.
  104. Seedat F, Hargreaves S, Nellums LB, et al. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Lancet Infect Dis. 2018;18(9):e259e271. doi:10.1016/S1473-3099(18)30117-8.
  105. Elisabeth M, Maneesh PS, Katarina SF, et al. Antimicrobial resistance & migrants in Sweden: Poor living conditions enforced by migration control policies as a risk factor for optimal public health management. Front Public Health. 2021;9:642983. doi:10.3389/fpubh.2021.642983.
  106. Mitsakakis K, Kaman WE, Elshout G, et al. Challenges in identifying antibiotic resistance targets for point‑of‑care diagnostics in general practice. Future Microbiol. 2018;13(10):11571164. doi:10.2217/fmb-2018-0084.
  107. Rattanaumpawan P, Boonyasiri A, Vong S, et al. Systematic review of electronic surveillance of infectious diseases with emphasis on antimicrobial resistance surveillance in resource‑limited settings. Am J Infect Control. 2018;46(2):139146. doi:10.1016/j.ajic.2017.08.006.
  108. Robert Koch Institut. Stellungnahme des Robert Koch‑Instituts zu Frage des Screenings von Asylsuchenden auf Multiresistente Erreger (MRE). 2016. Accessed June 10, 2024. https://www.rki.de/DE/Content/Infekt/Krankenhaushygiene/Screening-Asylsuchende-MRE.html.
  109. Taylor SL, Papanicolas LE, Flynn E, et al. Preventing empirical antibiotic treatment failure in migrant populations: Screening by infection risk, not ethnic background. Int J Infect Dis. 2023;134:168171. doi:10.1016/j.ijid.2023.06.014.
  110. Nielsen RT, Andersen , Schønheyder HC, et al. Differences in the distribution of pathogens and antimicrobial resistance in bloodstream infections in migrants compared with non‑migrants in Denmark. Infect Dis (Lond). March 2023;55(3):165174. doi:10.1080/23744235.2022.2151643. Epub 2022 Dec 22. PMID: 36548010.
DOI: https://doi.org/10.5334/aogh.4628 | Journal eISSN: 2214-9996
Language: English
Submitted on: Dec 1, 2024
Accepted on: Feb 1, 2025
Published on: Mar 6, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Sergio Cotugno, Elda De Vita, Luisa Frallonardo, Roberta Novara, Roberta Papagni, Muhammad Asaduzzaman, Francesco Vladimiro Segala, Nicola Veronese, Emanuele Nicastri, Anna Morea, Ferenc Balázs Farkas, Botond Lakatos, Roberta Iatta, Giovanni Putoto, Annalisa Saracino, Francesco Di Gennaro, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.